Abstract
This chapter highlights the important interactions between the CNS, the endocrine system and the immune system that influence the course of EAE. In particular, we focus on the bi-directional relationship between the hypothalamic-pituitary-adrenal (HPA) axis and EAE, and the influences of gender and sex hormones on EAE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
MacPhee, I. A., Antoni, F. A. & Mason, D. W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 169, 431–45 (1989).
del Rey, A., Klusman, I. & Besedovsky, H. O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1, Am J Physiol 275, Rl146–51 (1998).
Besedovsky, H. O. & del Rey, A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17, 64–102 (1996).
Bernton, E. W., Beach, J. E., Holaday, J. W., Smallridge, R. C. & Fein, H. G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238, 519–21 (1987).
Moyer, A., Jervis, G., Black, J., Koprowski, H. & Cox, H. Action of adrenocorticotrophic hormone in experimental allergic encephalomyelitis of the guinea pig. Proc Soc Exp Biol Med 75, 387 (1950).
Reder, A. T., Thapar, M. & Jensen, M. A. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 44, 2289–94 (1994).
Levine, S., Wenk, E. J., Muldoon, T. N. & Cohen, S. G. Enhancement of experimental allergic encephalomyelitis by adrenalectomy. Proc Soc Exp Biol Med 111, 383–5 (1962).
Bolton, C, O’Neill, J. K., Allen, S. J. & Baker, D. Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int Arch Allergy Immunol 114, 74–80 (1997).
Stefferl, A. et al. Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology 142, 3616–24 (2001).
Sternberg, E. M. et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A 86, 2374–8 (1989).
Mason, D., MacPhee, I. & Antoni, F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70, 1–5 (1990).
Levine, S., Strebel, R., Wenk, E. J. & Harman, P. J. Suppression of experimental allergic encephalomyelitis by stress. Proc Soc Exp Biol Med 109, 294–8 (1962).
Dowdell, K. C., Gienapp, I. E., Stuckman, S., Wardrop, R. M. & Whitacre, C. C. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis. J Neuroimmunol 100, 243–51 (1999).
Griffin, A. C., Lo, W. D., Wolny, A. C. & Whitacre, C. C. Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences. J Neuroimmunol 44, 103–16 (1993).
Padgett, D. A. & Glaser, R. How stress influences the immune response. Trends Immunol 24, 444–8 (2003).
Ashwell, J. D., Lu, F. W. & Vacchio, M. S. Glucocorticoids in T cell development and function*. Annu Rev Immunol 18, 309–45 (2000).
Elenkov, I. J. & Chrousos, G. P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966, 290–303 (2002).
Whitacre, C. C., Dowdell, K. & Griffin, A. C. Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 840, 705–16 (1998).
Smith, T., Schmied, M., Hewson, A. K., Lassmann, H. & Cuzner, M. L. Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis. J Autoimmun 9, 167–74 (1996).
Schmidt, J. et al. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123 (Pt 7), 1431–41 (2000).
Golde, S., Coles, A., Lindquist, J. A. & Compston, A. Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro. Eur J Neurosci 18, 2527–37 (2003).
Bakker, J. M. et al. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J Immunol 165, 5932–7 (2000).
Kim, S. & Voskuhl, R. R. Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 162, 5561–8 (1999).
Voskuhl, R. R., Pitchekian-Halabi, H., MacKenzie-Graham, A., McFarland, H. F. & Raine, C. S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 39, 724–33 (1996).
Mertin, L. A. & Rumjanek, V. M. Pregnancy and the susceptibility of Lewis rats to experimental allergic encephalomyelitis. J Neurol Sci 68, 15–24 (1985).
Evron, S., Brenner, T. & Abramsky, O. Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits. Am J Reprod Immunol 5, 109–13(1984).
Bebo, B. F., Jr., Vandenbark, A. A. & Offner, H. Male SJL mice do not relapse after induction of EAE with PLP 139–151. J Neurosci Res 45, 680–9 (1996).
Griffin, A. C. & Whitacre, C. C. Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease. J Neuroimmunol 35, 53–64 (1991).
Papenfuss, T.L., et al. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J. Neuroimmunol., in press, 2004.
Whitacre, C. C. Sex differences in autoimmune disease. Nat Immunol 2, 777–80 (2001).
Bebo, B. F., Jr. et al. Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 84, 122–30 (1998).
Dalai, M., Kim, S. & Voskuhl, R. R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 159, 3–6 (1997).
Bebo, B. F., Jr., Schuster, J. C., Vandenbark, A. A. & Offner, H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 162, 35–40 (1999).
Cua, D. J., Hinton, D. R. & Stohlman, S. A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 155, 4052–9 (1995).
Whitacre, C. C., Reingold, S. C. & O’Looney, P. A. A gender gap in autoimmunity. Science 283, 1277–8 (1999).
Gilmore, W., Weiner, L. P. & Correale, J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 158, 446–51 (1997).
Bebo, B. F., Jr. et al. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166, 2080–9 (2001).
Jansson, L., Olsson, T. & Holmdahl, R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 53, 203–7 (1994).
Matejuk, A. et al. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 65, 529–42 (2001).
Voskuhl, R. R. & Palaszynski, K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7, 258–70 (2001).
Kim, S., Liva, S. M, Dalai, M. A., Verity, M. A. & Voskuhl, R. R. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52, 1230–8 (1999).
Liu, H. B. et al. Estrogen receptor alpha mediates estrogen’s immune protection in autoimmune disease. J Immunol 171, 6936–40 (2003).
Ito, A. et al. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 167, 542–52 (2001).
Polanczyk, M. et al. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol 163, 1599–605 (2003).
Matejuk, A., Dwyer, J., Hopke, C., Vandenbark, A. A. & Offner, H. 17Beta-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis. Arch Immunol Ther Exp (Warsz) 51, 185–93 (2003).
Cid, M. C. et al. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 93, 17–25 (1994).
Matejuk, A., Dwyer, J., Zamora, A., Vandenbark, A. A. & Offner, H. Evaluation of the effects of 17beta-estradiol (17beta-e2) on gene expression in experimental autoimmune encephalomyelitis using DNA microarray. Endocrinology 143, 313–9 (2002).
Miyaura, H. & Iwata, M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 168, 1087–94 (2002).
Labombarda, F. et al. Cellular basis for progesterone neuroprotection in the injured spinal cord. J Neurotrauma 19, 343–55 (2002).
Langer-Gould, A., Garren, H., Slansky, A., Ruiz, P. J. & Steinman, L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. J Immunol 169, 1084–91 (2002).
Riskind, P. N., Massacesi, L., Doolittle, T. H. & Hauser, S. L. The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 29, 542–7 (1991).
Dijkstra, C. D. et al. The therapeutic effect of bromocriptine on acute and chronic experimental allergic encephalomyelitis. Ann Neurol 31, 450–1 (1992).
Rodriguez-Pena, A. Oligodendrocyte development and thyroid hormone. J Neurobiol 40, 497–512 (1999).
Calza, L., Fernandez, M., Giuliani, A., Aloe, L. & Giardino, L. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during EAE. Proc Natl Acad Sci U S A 99, 3258–63 (2002).
Ikushima, H., Kanaoka, M. & Kojima, S. Cutting edge: Requirement for growth hormone-releasing hormone in the development of experimental autoimmune encephalomyelitis. J Immunol 171, 2769–72 (2003).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Gilmore, C., Constantinescu, C.S., Whitacre, C.C. (2005). Hormonal and Gender Influences on Experimental Autoimmune Encephalomyelitis. In: Lavi, E., Constantinescu, C.S. (eds) Experimental Models of Multiple Sclerosis. Springer, Boston, MA. https://doi.org/10.1007/0-387-25518-4_26
Download citation
DOI: https://doi.org/10.1007/0-387-25518-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25517-0
Online ISBN: 978-0-387-25518-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)